What should you know about the Puma 560 surgical robot?

The Puma 560 was developed as a research system rather than the multi-instrument surgical platforms used in many hospitals today. Its design explored how a computer-controlled arm could position a surgical instrument along a planned path. Early work with systems like this helped establish ideas such as image guidance, controlled movement and surgeon-directed automation.

A robot does not independently decide what operation a patient needs. A trained surgical team selects the procedure, interprets scans and examination findings, and remains responsible for the operation. Modern systems generally translate the surgeon’s hand movements into controlled instrument movements and may provide a magnified view, but they still require careful planning and direct supervision.

Ask which current system is being used, what part of the operation it supports, and why that approach fits your tumour’s location and stage. Clarify whether the robot assists with keyhole access, instrument control or visualisation. You can also ask how the team would complete the operation if the robotic approach became unsuitable during surgery.

Review the expected incision sites, anaesthetic plan, possible need to change approach and the recovery activities relevant to your operation. The name Puma 560 refers to a historical device; it is not a recommendation to use that system for a present-day cancer procedure.

Before treatment, contact your surgical team if you develop new breathing difficulty, fever, worsening pain or a change in the symptoms that led to your assessment. After surgery, urgent review is appropriate for heavy bleeding, severe breathlessness, chest pain, fainting, confusion or a wound that is rapidly becoming red, swollen or draining.

Which robotic platform will be used, and what part of my operation will it perform? What are the alternatives for my tumour? How experienced is the team with this procedure? What signs after discharge should prompt an urgent call?